GlaxoSmithKline Biologicals S.A., commonly referred to as GSK Biologicals, is a leading global player in the biopharmaceutical industry, headquartered in Belgium. Founded in 1995, the company has established itself as a pioneer in vaccine development, focusing on innovative solutions to combat infectious diseases. With a strong operational presence across Europe, North America, and emerging markets, GSK Biologicals is dedicated to enhancing public health through its extensive portfolio of vaccines. The company’s core offerings include vaccines for diseases such as influenza, hepatitis, and meningitis, distinguished by their advanced research and development processes. GSK Biologicals has achieved notable milestones, including the introduction of several groundbreaking vaccines that have significantly impacted global health. As a subsidiary of GlaxoSmithKline plc, it continues to maintain a robust market position, recognised for its commitment to quality and innovation in the biopharmaceutical sector.
We don't have data for Glaxosmithkline Biologicals S.A., but we can show you information about their parent organization instead.
View parent company